You are here

  • Home
  • Archive
  • Volume 70, Issue Suppl 3
  • P122 Combination therapy with inhaled salmeterol plus fluticasone propionate is more effective than salmeterol alone in reducing the risk of clinically important deterioration in COPD: A post-hoc analysis of the TORCH trial

Article metrics

Article menu

Download PDFPDF

Poster sessions
Phenotypes and response to treatment in COPD
P122 Combination therapy with inhaled salmeterol plus fluticasone propionate is more effective than salmeterol alone in reducing the risk of clinically important deterioration in COPD: A post-hoc analysis of the TORCH trial
Free

 

Online download statistics by month:

Online download statistics by month: November 2015 to March 2024

AbstractFullPdf
Nov 20151501
Dec 20153702
Jan 20162301
Feb 20161701
Mar 2016102
Apr 2016802
May 2016602
Jun 20161202
Jul 20162002
Aug 20161301
Sep 2016901
Oct 20161201
Nov 2016702
Dec 2016501
Jan 20172111
Feb 20171101
Mar 20171301
Apr 2017801
May 20172501
Jun 20171102
Jul 20171600
Aug 20172400
Sep 20171801
Oct 20172400
Nov 20172202
Dec 20174000
Jan 20181001
Feb 20181600
Mar 20183601
Apr 20181602
May 20182001
Jun 20181000
Jul 20181400
Aug 20182000
Sep 20181600
Oct 20182001
Nov 20183600
Dec 20182001
Jan 20191004
Feb 2019001
Apr 2019305
May 20191406
Jun 2019404
Jul 2019802
Aug 2019700
Sep 2019702
Oct 2019001
Nov 20191006
Dec 2019802
Jan 2020402
Feb 2020603
Mar 2020202
Apr 2020204
May 2020601
Jun 2020802
Jul 2020801
Aug 2020203
Sep 2020800
Oct 2020402
Nov 2020202
Dec 2020003
Jan 2021602
Feb 2021004
Mar 20211202
Apr 2021200
May 2021403
Jun 2021001
Jul 2021003
Aug 2021003
Sep 2021005
Oct 20214017
Nov 20212010
Dec 20211200
Jan 2022200
Feb 2022201
Mar 2022602
Apr 2022401
May 2022608
Jun 20221802
Jul 2022600
Aug 2022803
Sep 20221108
Oct 2022403
Nov 2022805
Dec 2022800
Jan 2023603
Feb 2023400
Mar 2023400
Apr 2023202
May 2023403
Jun 2023801
Jul 2023802
Aug 2023400
Sep 2023601
Oct 2023401
Nov 2023602
Dec 20231000
Jan 2024400
Feb 20241201
Mar 202412017
Total9941212